Cumberland pharmaceuticals reports 2.5m patient doses delivered, no product recalls, no fda issues in 2020

Nashville, tenn., july 26, 2021 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company, today released its 2020 sustainability report, which details the company's activities pertaining to environmental, social and governance (esg) matters.

CPIX Ratings Summary

CPIX Quant Ranking